Ontak (Denileukin Diftitox)

DRUG2 trials

Sponsors

Eisai Inc., M.D. Anderson Cancer Center

Conditions

LeukemiaLymphoma, B-CellSystemic Mastocytosis

Phase 2

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

CompletedNCT00211276

Eisai Inc.Lymphoma, B-Cell

Start: 2005-03-31End: 2007-02-28Target: 50Updated: 2012-03-14

Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)

CompletedNCT00493129

M.D. Anderson Cancer CenterLeukemia, Systemic Mastocytosis

Start: 2004-07-31End: 2007-08-31Updated: 2012-02-08